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The differentiation of three anterior pituitary cell types is regulated by the tissue-speci®c POU domain factor Pit-1, which
is initially expressed on Embryonic Day 13.5±14 in mice. The Pit-1 gene remains continuously, highly expressed in the
somatotrope, thyrotrope, and lactotrope cells of the adult. Using the Pit-1-defective Snell dwarf as a genetic background,
we demonstrate that the Pit-1 gene utilizes distinct enhancers for initial gene activation and for subsequent autoregulation
(required for maintenance of expression) and that Pit-1-dependent activation of the distal enhancer can be mediated in the
absence of the early enhancer. These two distinct enhancers provide the basis for temporally speci®c regulation by discrete
pituitary-speci®c factors, events likely to be prototypic for regulation of other classes of genes encoding transcription factors
controlling terminal differentiation. q 1997 Academic Press
INTRODUCTION de®ned by the trophic hormone synthesized [corticotropes
(adrenocorticotrophin); thyrotropes (thyroid-stimulating
The pituitary gland produces a number of hormones hormone); somatotropes (growth hormone); lactotropes
which regulate every aspect of normal mammalian physiol- (prolactin); gonadotropes (luteinizing hormone and follicle-
ogy. Morphogenesis of the murine anterior pituitary gland is stimulating hormone)], activation of the genes encoding
histologically distinguishable at e8.5±9 as an invagination these hormones marks the appearance of a terminally differ-
from the roof of the oral ectoderm extending cranially entiated cell lineage in the anterior pituitary. Because of its
(Rathke's pouch), toward the ¯oor of the diencephalon. By relatively simple cellular composition, well-characterized
e12.5, Rathke's pouch is sealed off from the oropharynx and histology, and restricted pattern of hormone gene expres-
is in direct contact with a neural downgrowth protruding sion, the developing pituitary has become a valuable model
from the ectodermal ¯oor of the diencephalon that will with which to study gene activation during terminal differ-
develop into the posterior pituitary. Upon contact between entiation.
the neuroectoderm and Rathke's pouch, a wave of cellular Cell- and temporal-speci®c transcription of the growth
proliferation enlarges the anterior margin and eventually hormone (GH), prolactin (PRL), and thyroid-stimulating
obliterates the pouch. This cell±cell contact appears to ini- hormone b (TSHb) genes is under the control of the POU-
tiate a cascade of molecular events culminating in the de- domain transcription factor Pit-1 (reviewed in Voss et al.,
velopment of ®ve hormone-producing cell types arranged in 1992; Rhodes et al., 1994; Andersen et al., 1994). Evidence
spatially distinct regions during development of the anterior for a role for Pit-1 in pituitary morphogenesis was obtained
pituitary. Because the identity of each of these cell types is through the analysis of unique dwarf phenotypes in mice
and pituitary function anomalies in humans (Li et al., 1990;
Pfaf¯e et al., 1993). These phenotypes are characterized by1 Current address: London Regional Cancer Centre, 790 Commis-
an absence of circulating growth hormone, prolactin, andsioners Road, London, Ontario, Canada N6A 4L6.
TSH correlating with the presence of debilitating mutations2 Current address: Department of Biology, Indiana University,
in their respective Pit-1 genes. Studies of the naturally oc-Purdue University, 723 West Michigan Street, Indianapolis, IN
46202-5132. curring dwarf mouse strains, Snell and Jackson, demon-
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strated unequivocally that Pit-1 is a crucial early regulator itary-speci®c transgene expression which facilitated tumor
formation and establishment of a putative embryonic pitu-of pituitary development. In these mice, the lack of func-
tional Pit-1 results in a dramatically reduced gland size be- itary cell line (GHFT-1). Interestingly, prolactin, growth
hormone, and TSHb genes are not active in the GHFT-1cause the somatotrope, lactotrope, and thyrotrope cell lin-
eages, which normally constitute approximately 85% of the line, even though Pit-1 expression is comparable to that
of normal mouse pituitaries (Lew et al., 1993). Moreover,anterior pituitary, fail to terminally differentiate and prolif-
erate. Thus the transcriptional activation events controlled transient transfection assays with the GHFT-1 line, using a
variety of rat Pit-1 reporter genes, suggested that sequencesby Pit-1, downstream of its own temporal activation, are
critical for the expansion of the above three pituitary cell between03.1 and05.1 kb of the 5* ¯anking region provided
a degree of transcriptional speci®city to the GHFT-1 line.lineages. However, in these mice, the initial activation of
the Pit-1 gene occurred normally (Li et al., 1990), but was Recently, we have cloned the rat and hamster homologues
of the mouse 010.2-kb distal enhancer (390 bp) and ®ndnot well sustained aftere18 (Rhodes et al., 1993), indicat-
ing that the initial mechanism of Pit-1 gene activation is that this distal enhancer from all three species is more ac-
tive than the rat 03.1- and 05.1-kb region in pituitary cellPit-1-independent, but that sustained expression requires
Pit-1 autoregulation. lines, including the GHFT-1 embryonic line (Rhodes et al.,
in press).In the mouse pituitary, analogous to events in the rat,
Pit-1 gene expression is initially detectable at Embryonic Autoregulation of the Pit-1 gene has complicated the
analysis of transcriptional events which activate its expres-Day 14 (Crenshaw et al., 1989; Simmons et al., 1990; Dolle
et al., 1990; Rhodes et al., 1993; Japon et al., 1995). Because sion in development. Here we report a transgenic analysis,
including the breeding of speci®c transgenes into the Pit-1-Pit-1 serves to govern speci®cation of three anterior pitu-
itary cell lineages, understanding the molecular mechanism defective Snell genetic background, to establish that early
activation of the Pit-1 gene and its subsequent autoregula-by which the Pit-1 gene is activated and expression main-
tained will enable the identi®cation of factors which control tion are mediated by distinct enhancers. Each enhancer ap-
pears to function in a temporally speci®c fashion to sequen-preceding molecular events that govern pituitary cell speci-
®cation. tially direct high levels of early embryonic expression fol-
lowed by the autoregulatory events required to maintainDespite the presence of autoregulatory Pit-1 binding sites
and two cAMP-regulatory element binding (CREB) protein the mature Pit-1-dependent cell phenotypes.
binding motifs, the proximal promoter region of the Pit-1
gene was found to direct only low levels of transcriptional
activity in pituitary tumor cell lines (McCormick et al., MATERIALS AND METHODS
1990; Chen et al., 1990). It has been suggested that a pro-
moter sequence was partly responsible for pituitary cell- Transgene Construction
speci®c expression (McCormick et al., 1993). However,
The construction of 0327 Pit-1/LacZ, 0327 Pit-1/hGH, 014.8
proximal promoter sequence homology between human and Pit-1/LacZ, and 014.8 Pit-1/hGH have been described previously
rodent Pit-1 genes is unexpectedly low, as exempli®ed by (Rhodes et al., 1993). The 700-bp HincII/EcoRI fragment containing
the loss of one of the CREB protein sites in the human gene the mouse Pit-1 010.2-kb distal enhancer was fused to 0327 Pit-
(Pfaf¯e et al., 1992). To identify other more distal transcrip- 1/hGH by adding an NheI linker to the 5* HincII site. This resulted
in fusion of the distal enhancer in an inverse orientation relativetional regulatory regions in the rodent Pit-1 genes that
to the 0327 mouse Pit-1 promoter fragment to generate the ENH/might confer pituitary-speci®c expression, an in vivo analy-
0327 hGH transgene. The 03.5 Pit-1/hGH transgene was an inter-sis using transgenic mice was performed. This study re-
mediate plasmid construct described previously (Rhodes et al.,vealed that 14.8 kb of 5* ¯anking sequence was suf®cient
1993). Construction of a transgene containing 014.8 kb of mouseto direct high levels of pituitary-speci®c expression to the
Pit-1 gene 5* ¯anking DNA, but missing the 010.2-kb distal en-Pit-1 promoter, but that the promoter alone (0327 bp) was
hancer (014.8DENH), was done by removing a SpeI fragment of
inactive in all tissues of transgenic mice (Rhodes et al., 1.3 kb which encompasses the enhancer plus 615 bp of 5* sequence.
1993). Transient transfection studies identi®ed a 700-bp The 1.3-kb SpeI fragment was subcloned into pBKSII (HincII site
fragment (with a 390-bp core) located 010.2 kb upstream destroyed) and the HincII site at the 5* end of the enhancer was
of the Pit-1 transcription start site that conferred strong converted to a SpeI site using a linker. The 615-bp 5* region was
then puri®ed as a SpeI fragment and cloned into SpeI-digested014.8transcriptional activity on heterologous promoters in pitu-
Pit-1/hGH. The correct orientation of the 615-bp insertion wasitary cell lines (Rhodes et al., 1993). This enhancer region
con®rmed by DNA sequence analysis. This resulted in the removalcontains functional DNA binding sites for a variety of regu-
of a 687-bp segment composed of the 300-bp core enhancer se-latory factors, including vitamin D receptor, a retinoic acid
quence plus 387 bp of 5* sequence. A transgene containing 010 kbreceptor (RAR) element, which requires Pit-1 for function,
of mouse Pit-1 5* ¯anking sequence (010 Pit-1/hGH) was generateda long pituitary-speci®c element (PSE), which appears to
from 014.8 Pit-1/hGH by SalI/SpeI digestion to remove 5 kb of
bind as yet uncharacterized pituitary cell line-speci®c fac- 5* DNA, polishing of the ends, and religation. A transgene con-
tors, and three Pit-1 binding elements. taining the 03.1- to 05.1-kb SacI fragment of the rat Pit-1 gene
Lew et al. (1993) used 15 kb of rat Pit-1 gene 5* ¯anking was produced by fusing it to the mouse0327 Pit-1/hGH transgene.
DNA to drive expression of SV40 large T-antigen in The 03.1/05.1-kb SacI fragment was modi®ed with NotI linkers
at both ends and cloned 5* to the mouse Pit-1 promoter in 0327transgenic mice. Two transgenic founders exhibited pitu-
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Pit-1/hGH via a NotI site in the pBKSII multiple cloning sequence. DNA was genotyped for the presence of both dw Pit-1 alleles so
that embryos carrying the transgene and null for functional Pit-1The functionality of these transgenes was assessed by transient
transfection into HeLa and GC rat pituitary cell lines either alone, could be analyzed. In situ hybridization was carried out with anti-
sense cRNA generated from an approximately 300-bp EcoRI/BglIIin the case of GC cells, or cotransfected with a cytomegalovirus
promoter-driven rat Pit-1 expression vector (Chen et al., 1990). fragment of the hGH 3* untranslated region cloned into pBKSII.
The antisense cRNA was labeled with [35S]dUTP using the GeminiTransient transfections were performed as previously described
(Rhodes et al., 1993) and reporter gene activity was determined Riboprobe system (Promega) and puri®ed over a Sephadex G50 col-
umn. In situ hybridizations were carried out on sagittal sectionsby testing the conditioned media for transgene-derived hGH as
described below or by X-gal staining of glutaraldehyde-®xed cells of transgenic embryos as described previously (Jiang et al., 1996)
with 1 1 107 cpm/ml at 607C.for transgene-derived b-galactosidase (Calzonetti et al., 1995).
Immunocytochemistry was performed on pituitary sections as
described previously (Sawchenko et al., 1985). Brie¯y, mice were
perfusion-®xed and the pituitaries excised and stored in 4% para-Production and Screening of Transgenic Mice
formaldehyde/10% sucrose for 24 hr at 47C. Immunocytochemical
Transgenic mice were generated and screened for the presence detection of pituitary hormones was performed with free-¯oating,
of integrated transgene as described previously (Rhodes et al., 1993). 30-mm, sliding microtome sections. The free-¯oating sections were
Con®rmation of a single integration site for each transgenic line placed on nets and washed with 0.01 M K ±PBS, pH 7.4, and subse-
was determined by genomic Southern hybridization. b-Galactosi- quently incubated with the primary antibody diluted in 0.01 M K ±
dase transgene expression was determined as previously described PBS, 2% normal goat serum, 0.3% Triton X-100 for 48 hr at 47C.
(Rhodes et al., 1993), using the ONPG colorimetric assay. Whole- Sections were subsequently washed in K ±PBS and primary anti-
mount X-gal staining of mouse pituitaries, at room temperature, body was detected using rhodamine- or FITC-conjugated goat anti-
was performed as described by Calzonetti et al. (1995). Transgene rabbit IgG (TAGO) or TRITC- or FITC-conjugated goat anti-mouse
expression was assessed in tissue extracts using a highly speci®c antibody (Qualex). Sections were mounted onto plain gelatinized
hGH immunoradiometric assay (IRMA) (Nichols Institute, San slides. The following antibodies were obtained from the National
Juan Capistrano, CA) as described previously (Rhodes et al., 1993). Hormone and Pituitary Program and used at a 1:1000 dilution:
Transgene-derived hGH detected by IRMA was con®rmed by RNA rabbit anti-hACTH, rabbit anti-hTSHb, and rabbit anti-FSHb. De-
blot hybridization. Total RNA was extracted (Chomczynski et al., tection of mouse GH and hGH was performed using a 1:50 dilution
1987) from either pooled tissues or individual organs, including of mouse anti-hGH antibody (Biomeda) and a 1:80,000 dilution of
thymus, liver, brain, heart, testes, ovary and uterus, stomach, monkey anti-mouse GH, kindly provided by Dr. W. Van der Laan.
spleen, lung, kidney, abdominal wall, and pituitary. Four indepen- Mouse anti-b-galactosidase antibody (Promega) was used at a
dent pedigrees carrying 014.8 Pit-1/hGH and one line of Pit-1 ENH/ 1:1000 dilution as was polyclonal antibody AR27.9, kindly provided
0327 hGH transgene were analyzed. Fifty micrograms of total RNA by Dr. R. P. C. Shiu (University of Manitoba), to human PRL.
was fractionated on 2.2 M formaldehyde±agarose gels, transferred
to nitrocellulose membrane (Nitroplus 2000, MSI), and hybridized
to an 800-bp hGH 32P-labeled cDNA under high stringency condi-
RESULTStions (Thomas et al., 1980). RNA blots were generated from individ-
ual tissues from a single transgenic mouse or pooled tissues from
a particular transgenic line. Transgenic mouse pituitaries were Anterior Pituitary-Speci®c Expression Is Conferred
pooled within a pedigree and RNA blot hybridization was done by Different Regions of the Pit-1 Gene
with a 320-bp hGH SmaI/SphI fragment of the hGH gene encom-
Based on our previous in vitro studies identifying a distalpassing 3* untranslated sequence. The Snell dwarf (dw) mouse
enhancer region located 010.2 kb upstream of the transcrip-strain was maintained and genotyped as described previously (Lin
et al., 1994). Mice of established transgenic lines were bred to het- tion start site of the mouse Pit-1 gene and the observation
erozygote Snell mice to generate Snell heterozygotes carrying the that 14.8 kb of contiguous 5* ¯anking information was suf-
transgene. These heterozygotes were mated to produce dwarf (dw/ ®cient to target correct temporal and spatial patterns of
dw) pups carrying the transgene. transgenic expression (Rhodes et al., 1993), we devised a
strategy to investigate whether the010.2-kb Pit-1 enhancer
could function as an early and/or late autoregulatory en-
Immunocytochemistry (ICC) and in Situ hancer and whether there was distinct enhancer responsible
Hybridization (ISH) for initial gene activation events. A series of transgenes was
constructed containing the minimal mouse Pit-1 promoterMouse embryos were harvested at e13.5, e14.5, e15.5, and e16.5.
The embryos were dissected from the uterus and the chorionic fused to 14.8 kb of contiguous mouse 5* ¯anking sequence:
membranes and placenta were cut and peeled away to leave a free 14.8 kb of 5* ¯anking sequence from which the 010.2 kb
embryo. The embryo was dissected such that the head was placed enhancer (distal enhancer) had been removed;010.2 or03.5
into 10% buffered Formalin and allowed to stand at room tempera- kb of mouse Pit-1 5* ¯anking sequence; and 03.1 to 05.1
ture for 30 min to facilitate diffusion of the Formalin into the tissue kb rat Pit-1 5* ¯anking sequence fused to the mouse 0327
and then stored at 47C until ISH. The remainder of the embryo, promoter. Transgenes were constructed using either b-ga-
free of all maternal tissue, was placed into a 1.5-ml microcentrifuge
lactosidase (LacZ) or human growth hGH reporter genes.tube containing proteinase K digestion solution for isolation of
The activity of all transgenes was compared to that of trans-embryo DNA. This DNA was used to determine the presence or
genes containing the mouse Pit-1 promoter region aloneabsence of the transgene by DNA dot-blot hybridization as de-
(0327 bp of 5* DNA with a cAMP response element andscribed previously (Rhodes et al., 1993). In the case of breedings
between heterozygous Snell mice and transgenic lines, embryo one autoregulatory Pit-1 element).
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A total of 10 independent transgenic pedigrees carrying a which the enhancer was removed (014.8DENH) were gener-
ated (Fig. 2). Based on analysis of lines in which there was no0327-bp Pit-1 promoter fused to LacZ (5 lines) or hGH (7
lines) were generated. An average of 8 mature transgenic ectopic expression, the mean pituitary hGH concentration
varied from 20 to 60 ng hGH/mg protein, indicating expres-mice of each line were tested for pituitary transgene expres-
sion using an hGH immunoradiometric assay or a colori- sion levels 100- to 5000-fold less than that observed for
the014.8-kb Pit-1/hGH lines. These data demonstrated themetric assay for b-galactosidase activity. In addition, 11
other tissues (abdominal wall, brain, testes, ovary and critical importance of the 010.2-kb enhancer in main-
taining high levels of pituitary-speci®c transcription. Theseuterus, heart, kidney, liver, lung, spleen, stomach, thymus)
were monitored for ectopic transgene expression in 6 of the results also indicated that DNA regulatory regions outside
the010.2-kb enhancer, and not including the0327-bp Pit-110 0327-bp Pit-1 promoter pedigrees. In all tissues, 0327-
bp Pit-1 promoter transgene expression was not detected promoter, could direct very low level, but pituitary-speci®c,
expression in the adult. To identify this additional tran-compared to nontransgenic littermate pituitary extracts as
negative controls (data not shown). Promoter transgenes scriptional regulatory region, a series of transgenes was con-
structed containing different regions of the mouse and ratwere functional in transient cotransfection assays with a
rat Pit-1 expression vector in HeLa cells demonstrating con- Pit-1 5* ¯anking DNA. One region of particular interest
was a 2.0-kb sequence of the rat Pit-1 5* ¯anking region,struct integrity. Thus, promoter-speci®c elements impli-
cated in vitro in initial Pit-1 gene activation (McCormick extending from 03.1 to 05.1 kb, suggested by Lew et al.
(1993), using transfection assays to possess a putative em-et al., 1991) do not appear to be physiologically signi®cant.
In contrast, transgenes containing014.8 kb of contiguous bryonic, pituitary-speci®c transcriptional activating ele-
ment(s). This region was cloned and sequenced (Rhodes etPit-1 5* ¯anking DNA were expressed at a high level in
transgenic mouse pituitaries, as reported previously al., 1996, in press) and inserted upstream of the 0327-bp
mouse Pit-1 promoter. Additionally, a transgene containing(Rhodes et al., 1993). In 5 independent 014.8-kb Pit-1/LacZ
transgenic lines, with an average of 17 mice from each line 03.5 kb of contiguous mouse Pit-1 5* ¯anking DNA was
generated to test the promoter proximal regions of thetested for expression, this transgene was only expressed in
the anterior pituitary as determined by ONPG colorimetric mouse Pit-1 gene. These transgenes proved to be silent in
all adult tissues tested (Fig. 2, and data not shown), sug-assay (Fig. 1) and by whole-mount X-gal staining of excised
pituitaries (data not shown). Typically, an intense blue gesting that the transcriptional activity described by Lew
et al. (1993) was unique to the cell lines utilized in thosestaining of the anterior portion of the pituitary gland was
evident after a 5-min reaction at room temperature which studies and that the residual pituitary-speci®c transcrip-
tional activity seen with 014.8 DENH transgenic micecorresponds with the high level of b-galactosidase activity
(1±4 units/ng protein) found in 014.8-kb Pit-1/LacZ pitu- must reside elsewhere. Therefore, the distal enhancer repre-
sents the late Pit-1 autoregulatory enhancer, critical for ef-itaries. Of the ®ve 014.8-kb Pit-1/hGH transgenic mouse
lines established, three exhibited pituitary-speci®c expres- fective expression in the mature gland.
sion (15, 27, and 23). The mean level of pituitary hGH varied
between lines from 1000 (line 15) to 50,000 ng hGH/mg
Genetic Evidence of Distinct Enhancer Functionprotein (line 23). Variation in the level and extent of
transgene expression between transgenic lines has been rou- To begin to study initial activation events, the expression
of each transgene was evaluated at e14.5±e15.5, 1±2 daystinely observed when hGH is used as the reporter (e.g., Stew-
art et al., 1988; Russo et al., 1988; Baker et al., 1992). Thus, after initial activation of the endogenous Pit-1 gene. As ex-
pected, 014.8 kb directed effectual expression at e14±e1515 kb of contiguous mouse Pit-1 5* ¯anking DNA directed
anterior pituitary-speci®c expression of both reporter genes (Fig. 3); however, when the 700-bp distal, autoregulatory
enhancer was deleted from this information, the degree of(lacZ and hGH) to the anterior pituitary gland. The hGH
reporter was utilized in all additional studies. Pit-1 gene activation appeared equivalent. In contrast, over-
lapping sequences within the ®rst 5 kb of Pit-1 5* ¯ankingBecause the Pit-1-regulated distal enhancer is contained
within the 014.8-kb Pit-1 transgenes, we tested the ability DNA failed to target initial expression, while 10 kb of con-
tiguous 5* information permitted effectual transgene ex-of the enhancer itself to confer pituitary-speci®c expression
by fusing it to the promoter. In ®ve Pit-1 enhancer (ENH/ pression on e14.5±e15.5 (Fig. 3). These data suggest that
both the distal (autoregulated) enhancer and a second, dis-0327) transgenic lines that exhibited pituitary-speci®c ex-
pression, the hGH reporter expression ranged from a mean tinct region between 03.5 and 010 kb could independently
facilitate gene expression in the wild-type gland. Evenof 1460 ng hGH/mg protein (line 288) to 119,494 ng hGH/
mg protein (line 18) (Fig. 2). These values are similar to though autoregulation would be expected to occur coinci-
dent with initial expression of the endogenous Pit-1 gene,those obtained with the pituitary-speci®c 014.8-kb Pit-1/
hGH transgenic lines. Therefore, the distal enhancer is ca- and thus the 014.8-kb Pit-1 transgenes, the distal enhancer
could also harbor information contributing to initial Pit-1pable of directing high levels of expression in the anterior
pituitary gland. gene activation.
In the Pit-1-defective Snell dwarf (dw/dw) mouse, initialTo determine if the distal enhancer was solely responsible
for the pituitary-speci®c expression seen with the 014.8- expression of the Pit-1 gene is observed on e13.5±e14.5 (Li
et al., 1990), followed by progressive diminution of Pit-1kb Pit-1/hGH and LacZ constructs, transgenic mice in
Copyright q 1997 by Academic Press. All rights of reproduction in any form reserved.
AID DB 8472 / 6x18$$$342 01-07-97 13:23:25 dbal
184 DiMattia et al.
FIG. 1. Expression of the 014.8-kb Pit-1/LacZ transgene in a series of lines. (A) Schematic of the Pit-1 gene, with the de®ned 010.2-kb
distal enhancer illustrated with Pit-1 binding elements (P), the Pit-1-dependent retinoic acid response element (PRE), and the pituitary-
speci®c element (PSE) indicated. (B) Expression of LacZ reporter in individuals from independent lines. Number of mice analyzed shown
in parentheses.
gene expression prior to loss of speci®c cell populations Collectively, these data indicate that within 11 kb of
mouse Pit-1 5* ¯anking DNA two cis-active enhancers are(thyrotropes, lactotropes, somatotropes) postpartum. To ab-
rogate any effect of endogenous Pit-1 on the autoregulatory present and function differentially. The more proximal ele-
ments between 03.5 and 010 kb are required for the initialsites, the 014.8-kb Pit-1/hGH transgene was bred into the
Snell mouse line, which has a nonfunctional Pit-1 molecule activation of Pit-1 expression in the anterior pituitary gland,
while the distal enhancer serves as the postactivation, auto-(Li et al., 1990). Breeding of transgenes into the Snell mouse
background proved to be highly dif®cult, such that only regulated enhancer required to maintain the differentiated
state of the Pit-1-dependent cell types.three litters could be obtained for analysis in a 112-year pe-
riod. Mice heterozygous for the dw allele and carrying the
transgene were mated and embryos harvested at e15.5 for Anterior Pituitary Cell-Speci®c Transgene
genotyping and in situ hybridization analysis. In dw/dw Expression
mice harboring the 014.8-kb transgene, strong expression
was observed on e14.5±e15.5 (Fig. 4), con®rming that this Having established that 014.8 kb of Pit-1 ¯anking se-
quences contain elements for initial embryonic gene activa-sequence encompasses the information required for initial
gene activation. When this experiment was performed with tion and subsequent sustained autoregulated expression, we
assessed the cell-speci®c expression of the 014.8-kb Pit-a transgene under control of the distal enhancer fused to
the Pit-1 promoter (ENH/0327 hGH), no expression was 1/hGH transgene by performing immunocytochemistry on
coronal sections of adult pituitaries. Human growth hor-detectable on e14.5±e15.5 (Fig. 4); in contrast, in a wild-
type genetic background, the enhancer/promoter transgene mone antiserum demonstrated a dispersed population of
hGH-expressing cells throughout the anterior pituitary,was highly expressed at e14.5±e15.5 (data not shown). Thus,
the autoregulatory enhancer was alone incapable of mediat- whereas b-galactosidase antiserum showed a denser, more
extensive population of cells expressing the 014.8-kb Pit-ing initial Pit-1 gene expression, but was able to respond to
Pit-1 once expressed. Moreover, this activation of the iso- 1/LacZ transgene (Fig. 5 and data not shown). It is apparent
that this transgene is not expressed in the posterior pituitarylated distal enhancer appears to circumvent the normal Pit-
1 gene activating events. or in the melanotropes of the intermediate lobe (Fig. 5A).
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FIG. 2. Expression of Pit-1/hGH transgenes in mature pituitary gland. Transgene hGH reporter is under the control of 327 bp, 14.8 kb,
3.5 kb of Pit-1 gene 5* ¯anking DNA, or 014.8 kb with the 700-bp distal enhancer excised (014.8DENH); fusion of the distal enhancer
(010.7 to 010.2 kb) to 0327 of Pit-1 promoter (ENH/0327), or fusion of 03.1 to 05.1 of the rat Pit-1 gene to the mouse Pit-1 promoter
(03.1 to 05.1/0327). Number of mice analyzed in each group indicated in parentheses. Mean pituitary hGH content was determined in
individual mouse pituitary extracts using an hGH IRMA and plotted on a log scale for each independent transgenic line. The numerical
designation for each line is given on the X axis and grouped according to the transgene they carry. Ten to 35 mice were tested from each
line for pituitary transgene expression and 3±6 mice/line were tested for ectopic expression as described under Materials and Methods.
Transgenic pituitary hGH was undetectable in the 0327-bp Pit-1 promoter lines; the 03.5-kb Pit-1 lines and the three lines carrying the
03.1- to 05.1-kb region of the rat Pit-1 gene fused to the mouse 0327-bp promoter (03.1 to 05.1/0327). This latter transgene contains
the putative tissue-speci®c enhancer region (2.1-kb SacI fragment) described by Lew et al. (1993) in the rat Pit-1 gene. Transgene-derived
hGH was readily detected in lines carrying 014.8 kb of contiguous mouse Pit-1 ¯anking DNA and lines containing the distal (010.2 kb)
enhancer (700-bp EcoRI/HincII fragment) fused to 0327-bp promoter region. Signi®cantly lower levels of transgene expression were
observed in mice harboring the 014.8DENH transgene. Error bars indicate the standard error of the mean for each line.
Immunocytochemical double-staining was performed to de- tional regulatory elements found in 014.8 kb of Pit-1 5*
¯anking DNA are also suf®cient to correctly restrict expres-termine if the 014.8-kb Pit-1/hGH transgene maintained
normal speci®city and was excluded from the corticotrope sion to the appropriate Pit-1-expressing cell types of the
anterior pituitary gland.and gonadotrope population. Double-staining reveals that
separate populations of cells expressed 014.8-kb Pit-1-de-
rived hGH and endogenously produced ACTH (cortico-
tropes) and FSHb (gonadotropes) (Figs. 5B and 5C). There- DISCUSSION
fore, the 014.8-kb Pit-1/hGH transgene is expressed in cell
types of the anterior pituitary that normally express the Genetic evidence has con®rmed that Pit-1 exerts a pivotal
role in pituitary organogenesis (Li et al., 1990; Pfaf¯e etendogenous Pit-1 gene. Clear colocalization was observed
in double-immunostaining experiments with anti-TSHb al., 1993), with the lack of thyrotropes, somatotropes, and
lactotropes in adult homozygous Snell dwarf mice indicat-antibody and demonstrated that the 014.8-kb Pit-1/hGH
transgene was expressed in thyrotropes, but the amount ing that Pit-1 is important in the proliferation and/or main-
tenance of these cell types. In the case of the somatotrope,of transgene expression in the somatotrope and lactotrope
populations was somewhat dif®cult to quantitate because this is exempli®ed by the fact that Pit-1 regulates growth
hormone releasing-factor receptor (GRFR) gene expression,of some cross-reactivity of the antisera to mouse hormones
(data not shown). These data suggested that the transcrip- the ligand for which controls not only GH secretion but
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FIG. 3. Mouse Pit-1/hGH transgenes recapitulate expression of the endogenous gene during development. Dark®eld micrographs of ®xed
midsagittal sections through the developing pituitary of e14.5±e15.5 mouse embryos hybridized to an 35S-labeled hGH-speci®c cRNA
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FIG. 4. Expression of the 014.8-kb Pit-1/hGH transgene in a Pit-1 minus (dw/dw) genetic background. Top: In situ hybridization of
e15.5 pituitary section from a mouse embryo homozygous for the Snell Pit-1 allele showing expression of the 014.8-kb Pit-1/hGH
transgene. Bottom: A section from a homozygous Snell e15.5 pituitary carrying the 10.2-kb enhancer fused to a 0327-bp mouse Pit-1
promoter/hGH transgene.
also proliferation of a portion of the somatotrope population The current study was directed at the regulation in vivo
of initial Pit-1 gene expression and its subsequent autoregu-(Lin et al., 1993; Godfrey et al., 1993). The Pit-1 gene is
activated relatively early in murine development (e13.5± lation. In this manuscript, we have established that expres-
sion of the 014.8-kb Pit-1 transgenes is targeted to the cor-e14.5) and precedes expression of its target genes, which
include growth hormone, prolactin, and TSHb, but remains rect cell types in the adult anterior pituitary and in the
developing gland, while the 327-bp proximal promoter re-expressed continuously thereafter.
Using transient transfection assays of de®ned pituitary gion of the Pit-1 gene, containing an autoregulatory Pit-
1 binding site and a CRE, was unable to drive detectabletumor cell lines, we had previously identi®ed a 390-bp en-
hancer located 10 kb upstream of the mouse Pit-1 gene expression of hGH or LacZ reporter genes. These data indi-
cate that the Pit-1 promoter, which includes a Pit-1 bindingtranscription start site (Rhodes et al., 1993). This enhancer
contains three functional Pit-1 binding sites, a pituitary- site and a putative pituitary-speci®c element surrounding
the rat Pit-1 TATA box (McCormick et al., 1991), does notspeci®c element, an element that preferably binds the vita-
min D3 receptor, and a retinoic acid response element that contain cis-elements suf®cient to activate the transcription
during normal development.mediates Pit-1-dependent retinoic acid receptor induction.
Although the activity of this enhancer is easily discernible To test whether the010.2-kb enhancer was solely respon-
sible for the robust pituitary-speci®c expression seen within immortalized pituitary cell lines, it was unclear whether
this enhancer was alone suf®cient to facilitate embryonic the 014.8-kb Pit-1 transgenes, the enhancer was fused to
the 0327-bp promoter region of the mouse Pit-1 gene. Theactivation or continuous expression of the Pit-1 gene during
development. ability of the 010.2-kb enhancer alone to establish a level
probe. Black box denotes distal enhancer (010.2 to 010.9 kb). A high level of expression of the 014.8-kb transgene (line 23) at e15.5 in
the anterior portion of the developing pituitary. No hybridization signal was observed in transgenic pituitaries from 0327-bp mPit-1
promoter lines at e15.5 (data not shown). An intense hybridization signal was evident on e14.5 pituitary sections taken from mice carrying
a fusion of the distal enhancer DE (010.7 to 010.2 kb) to 0327 of Pit-1 promoter (ENH/0327) (data not shown). E15.5 014.8DENH
transgenic pituitary section exhibited distinct hybridization to the anterior pituitary. No hybridization signals were observed with sections
from e15.5 transgenic mouse embryos carrying the 03.5-kb Pit-1/hGH or 03.1- to 05.1-kb rat Pit-1 gene fused to the mouse 0327-bp
promoter (03.1 to 05.1 kb).
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VDRE), which could contribute to homeostatic gene regula-
tion throughout the normal life span of the mouse.
In contrast, two transgenes encompassing the initial 05
kb of mouse Pit-1 5* ¯anking DNA (03.5-kb mouse and
03.1- to 05-kb rat Pit-1) were not activated in the adult
mouse pituitary. These data suggest that a regulatory region
previously identi®ed by transfection analysis in a pituitary
cell line (GHFT1) (Lew et al., 1993) cannot act indepen-
dently in vivo to activate pituitary-speci®c gene expression.
The GHFT1 line was derived from a pituitary tumor gener-
ated in transgenic mice carrying SV40 large T antigen driven
by 015 kb of rat Pit-1 5* ¯anking DNA; in this cell line the
Pit-1 gene is active but its target genes, prolactin and growth
hormone, are quiescent. Because our data suggest that a
transcriptional regulatory element found in the 03.1- to
05.1-kb region (reported to be active in GHFT1 cells) fails
to operate in vivo, the GHFT1 line may re¯ect a stage of
differentiation distinct from that at which the Pit-1 is ini-
tially activated. Collectively, these data imply that the tran-
scriptional activating sequences found in the 014.8DENH
hGH transgene are beyond 05 kb. Consistent with this pre-
FIG. 5. Cell-speci®c expression of the 014.8-kb Pit-1/hGH in diction, 010 kb of 5* ¯anking information recapitulated
adult pituitary determined by immunocytochemical double-stain- the temporal patterns of endogenous Pit-1 gene activation,
ing. (A) A coronal section through a transgenic adult pituitary indicating that cooperation between the late enhancer and
stained with antiserum speci®c to hGH and visualized with a sec- 010-kb regions is not necessary for initial gene activation.
ondary antibody conjugated to ¯uorescein (501 magni®cation)
The 010.2-kb enhancer contains three important Pit-1transgenic pituitaries. A dispersed population of anterior pituitary
autoregulatory sites (Rhodes et al., 1993), characteristic ofcells expresses the transgene. Similar data were observed for the
enhancers of genes encoding a variety of developmental reg-LacZ transgene (data not shown). A series of double immunohisto-
ulatory factors, such as C/EBP (Timchenko et al., 1995),chemical staining experiments using 014.8-kb mPit-1/hGH (2001
magni®cation) was performed to determine if the transgene was GATA-1 (Simon et al., 1992), and Hox-4.2 (Popperl et al.,
expressed in corticotropes and gonadotropes. Secondary antisera 1992). To de®nitively test whether the 010.2-kb enhancer
conjugated to rhodamine were used to localize hormone-secreting could initiate Pit-1 gene activation in the absence of auto-
cell types. (B) Double-staining for 014.8-kb Pit-1 transgene-derived regulatory functions, it was necessary to determine whether
hGH and ACTH, indicating that transgene is not expressed in corti- the014.8-kb Pit-1/hGH transgene was functional in a Pit-1-
cotropes. (C) Transgene expression was not detected in gonado- negative genetic background. We established that the distal
tropes as shown using antibody to FSHb. In B and C, the occasional
enhancer itself, while fully effective in autoregulated ex-yellow color corresponds to overlap of two independently stained
pression, was incapable of mediating initial activation incells.
the Pit-1-negative genetic background. This result is in con-
cert with the ®ndings in homozygous Snell Pit-1-defective
mice in which initial Pit-1 gene activation is temporally
and spatially unhindered, diminishing only later in develop-of pituitary transgene expression similar to that observed
using a contiguous 15-kb fragment of mouse Pit-1 5* ment (Rhodes et al., 1993).
Together, these data suggest that those transient factors¯anking DNA implies that the elements comprising the
isolated enhancer are suf®cient to permit anterior pituitary- responsible for the normal activation of the Pit-1 gene dur-
ing early pituitary development interact with elements con-speci®c gene expression. Conversely, a transgene con-
taining 14.8 kb of mouse Pit-1 5* ¯anking DNA with the tained within two distinct regions of014.8 kb of 5* ¯anking
DNA. The absence of transgene activity under control of the010.2-kb enhancer excised was ineffective at directing ex-
pression in the mature anterior pituitary gland, having been 010.2-kb enhancer in mice lacking functional Pit-1 implies
that this enhancer serves only to target Pit-1 autoregulation,expressed at levels 1000-fold lower than the intact 014.8-
kb Pit-1/hGH transgene. However, this transgene indicated and hence in a Pit-1-expressing mouse, will be activated
coincident with activation of the endogenous Pit-1 gene atthat elements outside the 010.2-kb distal enhancer, not
detected by transient transfection, were capable, albeit very e14. This is analogous to events in mice carrying trans-
genes composed of multiple copies of particular cis-activeineffectively, of establishing pituitary-speci®c transcrip-
tional activation. Therefore, both the 010.2-kb distal en- elements (e.g., retinoic acid receptor elements; Lernbecher
et al., 1993; Rossant et al., 1991).hancer and pituitary-targeting elements separate from the
distal enhancer could function independently. The 010.2- Of the two independent mouse Pit-1 regions that can
guide embryonic activation, only one is readily detectablekb distal enhancer contains autoregulatory and other ele-
ments, such as hormone-inducible elements (i.e., PRE, by transient transfection assays in available cell lines. These
Copyright q 1997 by Academic Press. All rights of reproduction in any form reserved.
AID DB 8472 / 6x18$$$343 01-07-97 13:23:25 dbal
189Developmental Pit-1 Gene Activation
FIG. 6. Expression of hGH transgenes in mouse pituitary directed by various segments of the mouse and rat Pit-1 genes. Summary of
early and late expression of Pit-1 transgenes, indicating a very low but detectable expression level of early and late enhancers for initial
(e14±e16) and late (mature gland) expression.
data imply that the activating elements in the more proxi- tional activating mechanism governing the initial develop-
ment of Pit-1-dependent cell lineages in the anterior pitu-mal region (Fig. 6) bind factors that are likely to be uniquely
expressed in the developing pituitary or at least expressed itary and the activation of the Pit-1 gene.
at much higher levels than in the mature gland. The more
proximal transcriptional activating region (03.5 to 010.2
kb) appears to function primarily in the initiation of Pit-1 ACKNOWLEDGMENTS
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